Repligen (RGEN) Net Income towards Common Stockholders (2010 - 2026)
Repligen (RGEN) reported Net Income towards Common Stockholders of $8.3 million for Q1 2026, up 42.93% year-over-year from $5.8 million in Q1 2025, and down 37.28% on a QoQ basis from $13.3 million in Q4 2025.
Repligen (RGEN) has 17 years of Net Income towards Common Stockholders data on file, last reported at $8.3 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 42.93% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.4 million (up 230.0% YoY) and the FY2025 annual result came in at $48.9 million, up 216.22% from the prior year.
- Net Income towards Common Stockholders fell to $8.3 million in Q1 2026 per RGEN's latest filing, from $13.3 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $49.9 million in Q2 2022 and bottomed at -$50.4 million in Q4 2024.
- The 5-year median for Net Income towards Common Stockholders is $14.9 million (2025), against an average of $15.8 million.
- The widest annual swing landed in 2024, when Net Income towards Common Stockholders plunged 2210.8%; it then surged 2380.12% in 2025.
- Tracing RGEN's Net Income towards Common Stockholders over 5 years: stood at $48.7 million in 2022, then plunged by 95.1% to $2.4 million in 2023, then sank by 2210.8% to -$50.4 million in 2024, then jumped by 126.35% to $13.3 million in 2025, then plunged by 37.28% to $8.3 million in 2026.
- Per Business Quant, the three latest RGEN Net Income towards Common Stockholders figures stand at $8.3 million (Q1 2026), $13.3 million (Q4 2025), and $14.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 398.73 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 135.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 13.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 130.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 72.77 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn | 8.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.33 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | -50.43 Mn |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 2.39 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 19.79 Mn |
| Mar 31, 2023 | 28.83 Mn |
| Dec 31, 2022 | 48.73 Mn |
| Sep 30, 2022 | 40.41 Mn |
| Jun 30, 2022 | 49.86 Mn |
| Mar 31, 2022 | 47.35 Mn |
| Dec 31, 2021 | 29.11 Mn |
| Sep 30, 2021 | 33.50 Mn |
| Jun 30, 2021 | 36.23 Mn |
| Mar 31, 2021 | 47.35 Mn |
| Dec 31, 2020 | 13.80 Mn |
| Sep 30, 2020 | 14.55 Mn |
| Jun 30, 2020 | 15.86 Mn |
| Mar 31, 2020 | 9.82 Mn |
| Dec 31, 2019 | 54,000.00 |
| Sep 30, 2019 | 1.66 Mn |
| Jun 30, 2019 | 8.10 Mn |
| Mar 31, 2019 | 8.05 Mn |
| Dec 31, 2018 | 5.64 Mn |
| Sep 30, 2018 | 4.79 Mn |
| Jun 30, 2018 | 2.74 Mn |
| Mar 31, 2018 | 3.45 Mn |
| Dec 31, 2017 | 12.18 Mn |
| Sep 30, 2017 | 4.67 Mn |
| Jun 30, 2017 | 8.44 Mn |
| Mar 31, 2017 | 3.07 Mn |
| Dec 31, 2016 | 5.03 Mn |
| Sep 30, 2016 | 1.16 Mn |
| Jun 30, 2016 | 3.87 Mn |
| Mar 31, 2016 | 1.63 Mn |
| Dec 31, 2015 | 265,000.00 |
| Sep 30, 2015 | 2.54 Mn |
| Jun 30, 2015 | 3.61 Mn |
| Mar 31, 2015 | 2.93 Mn |
| Dec 31, 2014 | -398,000.00 |
| Sep 30, 2014 | 1.47 Mn |
| Jun 30, 2014 | 2.83 Mn |
| Mar 31, 2014 | 4.28 Mn |
| Dec 31, 2013 | 3.33 Mn |
| Sep 30, 2013 | 5.89 Mn |
| Jun 30, 2013 | 4.54 Mn |
| Mar 31, 2013 | 2.34 Mn |
| Dec 31, 2012 | 9.55 Mn |
| Sep 30, 2012 | 1.81 Mn |
| Jun 30, 2012 | 1.57 Mn |
| Sep 30, 2011 | 605,000.00 |
| Jun 30, 2011 | -55,000.00 |
| Mar 31, 2011 | -2.03 Mn |
| Dec 31, 2010 | 375,916.00 |
| Sep 30, 2010 | 623,209.00 |
| Jun 30, 2010 | 988,053.00 |